Announcements
The latest Impact Factors have been released and are updated in our site!Not a Current Subscriber?
Subscribe Now
5642 Journals
4485 Congresses
10100+ Unique Records
EMBO Molecular Medicine
Title Abbreviation
EMBO Mol Med
ISSN
1757-4676
Electronic ISSN
1757-4684
Therapeutic Area
Readership
Bioinformaticists, Biologists, Biomedical Engineers/Technologists, Biomedical Researchers, Geneticists, Immunologists, Molecular Biologists, Pharmaceutical Scientistists
Scope
EMBO Molecular Medicine is an open access journal in the field of experimental medicine, dedicated to science at the interface between clinical research and basic life sciences. In addition to human data, we welcome original studies performed in cells and/or animals provided they demonstrate human disease relevance.
To enhance and better specify our commitment to precision medicine, we have expanded the scope of EMM and call for contributions in the following fields:
Environmental health and medicine, in particular studies in the field of environmental medicine in its functional and mechanistic aspects (exposome studies, toxicology, biomarkers, modeling, and intervention).
Clinical studies and case reports - Human clinical studies providing decisive clues how to control a given disease (epidemiological, pathophysiological, therapeutic, and vaccine studies). Case reports supporting hypothesis-driven research on the disease.
Biomedical technologies - Studies that present innovative materials, tools, devices, and technologies with direct translational potential and applicability (imaging technologies, drug delivery systems, tissue engineering, and AI).
The journal is one of four EMBO Press journals run by in-house professional scientific editors. EMBO Molecular Medicine is supported by our academic Chief Editor, Prof. Philippe Sansonetti, and our broad and diverse advisory editorial board. Our journal is editorially independent of its publisher Springer Nature. For further details on our relationship to other EMBO Press publications, please see below.
EMBO Molecular Medicine publishes research papers as full-length Articles, short Reports, Methods and Resource articles. In addition, the journal publishes Editorials and Reviews in innovative formats that target a broad and non-specialized audience, as well as News & Views, Opinions and Comments.
Areas covered include, but are not limited to:
Vascular and cardiovascular biology;
Infectious diseases and vaccines;
Microbiome;
Endocrinology and metabolic diseases;
Stem cells and regenerative medicine;
Systems medicine and clinical genomics;
Aging;
Neurodegeneration and neurological diseases;
Myopathies and musculoskeletal disease;
Gene and cell therapy;
Human genetics, autoimmunity, and rare diseases;
Immunology and inflammation;
Oncology;
Molecular diagnostics, biomarkers and imaging;
Drug discovery;
Mitochondrial diseases;
Gastroenterology;
Nephrology;
Respiratory diseases;
Reproductive medicine;
Biomedical technologies;
Human clinical studies;
Case reports;
Exposome studies;
Toxicology.
Sponsoring Association(s)
European Molecular Biology Organization (EMBO)
Publisher Name
EMBO Press
Testimonials
| "PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection." | |
|
– Kait G
Editorial-Project Editor
| |
| "It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly" | |
|
– Michael K.
Medical Communications Leader
|
|
| "…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research." | |
|
- Weill Cornell Medical Library
|
|
Journals ● Congresses ● Associations
Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us
Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us
Copyright ©2024 ICON plc ● All Rights Reserved ● Version 11.9
